Literature DB >> 12134030

The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction.

Tatiana Bousse1, Tatyana Matrosovich, Allen Portner, Atsushi Kato, Yoshiyuki Nagai, Toru Takimoto.   

Abstract

Sendai virus (SV) and human parainfluenza virus type 1 (hPIV1) have genomes consisting of nonsegmented negative-sense RNA in which the six genes are separated by well-conserved intergenic (IG) sequences and transcriptional start (S) and end signals. In hPIV1-infected cells, transcriptional termination at the M-F gene junction is ineffective; a large number of M-F read-through transcripts are produced (T. Bousse, T. Takimoto, K. G. Murti, and A. Portner, Virology 232:44-52, 1997). In contrast, few M-F read-through transcripts are detected in SV-infected cells. Sequence analysis indicated that the hPIV1 IG and S sequences in the M-F junction differ from those of SV. Furthermore, the hPIV1 F gene contains an unusually long noncoding sequence. To identify the cis-acting elements that prevent transcriptional termination at the M-F junction, we rescued recombinant SV (rSVhMFjCG) in which its M-F gene junction was replaced by that of hPIV1. Cells infected with rSVhMFjCG produced an abundance of M-F read-through transcripts; this result indicated that the hPIV1 M-F junction is responsible for inefficient termination. When one or both of the IG and S sites in rSVhMFjCG were replaced by those of SV, the efficiency of transcriptional termination increased but not to the level observed in wild-type SV-infected cells. Deletion of most of the long noncoding region of the hPIV1 F gene in rSVhMFjCG in addition to the mutations in IG and S signals resulted in efficient termination that was equivalent to the level observed in wild-type virus-infected cells. Therefore, the long noncoding sequence of the hPIV1 F gene contains cis-acting element(s) that affects transcriptional termination. Our evaluation of the effect of inefficient transcriptional termination on viral replication in culture revealed that cells infected with rSVhMFjCG produced less F protein than cells infected with wild-type SV and that assembly of the recombinant SV in culture was less efficient. These phenotypes seem to be responsible for the extended survival of mice infected with rSVhMFjCG.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134030      PMCID: PMC155142          DOI: 10.1128/jvi.76.16.8244-8251.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription.

Authors:  J N Barr; S P Whelan; G W Wertz
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome.

Authors:  L Kuo; R Fearns; P L Collins
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Polytranscripts of Sendai virus do not contain intervening polyadenylate sequences.

Authors:  K C Gupta; D W Kingsbury
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

5.  Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses.

Authors:  M K Spriggs; R A Olmsted; S Venkatesan; J E Coligan; P L Collins
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

6.  Role of matrix and fusion proteins in budding of Sendai virus.

Authors:  T Takimoto; K G Murti; T Bousse; R A Scroggs; A Portner
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Newcastle disease virus-specific RNA: an analysis of 24 S and 35 S RNA transcripts.

Authors:  N L Varich; I S Lukashevich; N V Kaverin
Journal:  Acta Virol       Date:  1979-07       Impact factor: 1.162

8.  Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map.

Authors:  M K Spriggs; P L Collins
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

9.  Molecular cloning and expression of human parainfluenza virus type 1 L gene.

Authors:  T Takimoto; T Bousse; A Portner
Journal:  Virus Res       Date:  2000-09       Impact factor: 3.303

10.  Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion.

Authors:  T Bousse; T Takimoto; W L Gorman; T Takahashi; A Portner
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

View more
  25 in total

1.  Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.

Authors:  Tatiana Bousse; Toru Takimoto
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Mutants of the Paf1 complex alter phenotypic expression of the yeast prion [PSI+].

Authors:  Lisa A Strawn; Changyi A Lin; Elizabeth M H Tank; Morwan M Osman; Sarah A Simpson; Heather L True
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

3.  The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.

Authors:  Matthias Lingemann; Sonja Surman; Emérito Amaro-Carambot; Anne Schaap-Nutt; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

4.  Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation.

Authors:  Kristina Brauburger; Yannik Boehmann; Yoshimi Tsuda; Thomas Hoenen; Judith Olejnik; Michael Schümann; Hideki Ebihara; Elke Mühlberger
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

5.  Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity.

Authors:  Makoto Takeda; Shinji Ohno; Fumio Seki; Yuichiro Nakatsu; Maino Tahara; Yusuke Yanagi
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Coordinate deletion of N-glycans from the heptad repeats of the fusion F protein of Newcastle disease virus yields a hyperfusogenic virus with increased replication, virulence, and immunogenicity.

Authors:  Sweety Samal; Sunil K Khattar; Sachin Kumar; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

7.  Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.

Authors:  Laura E Luque; Olga A Bridges; John N Mason; Kelli L Boyd; Allen Portner; Charles J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

9.  Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles.

Authors:  Raychel Chambers; Toru Takimoto
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

10.  Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

Authors:  Toru Takimoto; Julia L Hurwitz; Chris Coleclough; Cecilia Prouser; Sateesh Krishnamurthy; Xiaoyan Zhan; Kelli Boyd; Ruth A Scroggs; Brita Brown; Yoshiyuki Nagai; Allen Portner; Karen S Slobod
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.